Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients

Systemic lupus erythematosus (SLE) is an inflammatory rheumatic disease characterized by production of autoantibodies and organ damage. Elevated levels of cytokines have been reported in SLE patients. In this study we have investigated the effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β)...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinod Umare, Vandana Pradhan, Milind Nadkar, Anjali Rajadhyaksha, Manisha Patwardhan, Kanjaksha K. Ghosh, Anita H. Nadkarni
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/385297
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560711939653632
author Vinod Umare
Vandana Pradhan
Milind Nadkar
Anjali Rajadhyaksha
Manisha Patwardhan
Kanjaksha K. Ghosh
Anita H. Nadkarni
author_facet Vinod Umare
Vandana Pradhan
Milind Nadkar
Anjali Rajadhyaksha
Manisha Patwardhan
Kanjaksha K. Ghosh
Anita H. Nadkarni
author_sort Vinod Umare
collection DOAJ
description Systemic lupus erythematosus (SLE) is an inflammatory rheumatic disease characterized by production of autoantibodies and organ damage. Elevated levels of cytokines have been reported in SLE patients. In this study we have investigated the effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in 145 Indian SLE patients. One hundred and forty-five healthy controls of the same ethnicity served as a control group. Clinical disease activity was scored according to SLEDAI score. Accordingly, 110 patients had active disease and 35 patients had inactive disease. Mean levels of IL-6, TNF-α, and IL-1β were found to be significantly higher in SLE patients than healthy controls (P<0.001). Mean level of IL-6 for patients with active disease (70.45±68.32 pg/mL) was significantly higher (P=0.0430) than those of inactive disease patients (43.85±63.36 pg/mL). Mean level of TNF-α was 44.76±68.32 pg/mL for patients with active disease while it was 25.97±22.03 pg/mL for those with inactive disease and this difference was statistically significant (P=0.0161). Similar results were obtained for IL-1β (P=0.0002). Correlation between IL-6, TNF-α, and IL-1β serum levels and SLEDAI score was observed (r=0.20, r=0.27, and r=0.38, resp.). This study supports the role of these proinflammatory cytokines as inflammatory mediators in active stage of disease.
format Article
id doaj-art-09e41c777dc94d4882118fe922e677d3
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-09e41c777dc94d4882118fe922e677d32025-02-03T01:26:46ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/385297385297Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE PatientsVinod Umare0Vandana Pradhan1Milind Nadkar2Anjali Rajadhyaksha3Manisha Patwardhan4Kanjaksha K. Ghosh5Anita H. Nadkarni6National Institute of Immunohaematology, Indian Council of Medical Research, Mumbai, Maharashtra 400012, IndiaNational Institute of Immunohaematology, Indian Council of Medical Research, Mumbai, Maharashtra 400012, IndiaDepartment of Rheumatology, King Edward Memorial Hospital, Parel, Mumbai, Maharashtra 400012, IndiaDepartment of Rheumatology, King Edward Memorial Hospital, Parel, Mumbai, Maharashtra 400012, IndiaNational Institute of Immunohaematology, Indian Council of Medical Research, Mumbai, Maharashtra 400012, IndiaNational Institute of Immunohaematology, Indian Council of Medical Research, Mumbai, Maharashtra 400012, IndiaNational Institute of Immunohaematology, Indian Council of Medical Research, Mumbai, Maharashtra 400012, IndiaSystemic lupus erythematosus (SLE) is an inflammatory rheumatic disease characterized by production of autoantibodies and organ damage. Elevated levels of cytokines have been reported in SLE patients. In this study we have investigated the effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in 145 Indian SLE patients. One hundred and forty-five healthy controls of the same ethnicity served as a control group. Clinical disease activity was scored according to SLEDAI score. Accordingly, 110 patients had active disease and 35 patients had inactive disease. Mean levels of IL-6, TNF-α, and IL-1β were found to be significantly higher in SLE patients than healthy controls (P<0.001). Mean level of IL-6 for patients with active disease (70.45±68.32 pg/mL) was significantly higher (P=0.0430) than those of inactive disease patients (43.85±63.36 pg/mL). Mean level of TNF-α was 44.76±68.32 pg/mL for patients with active disease while it was 25.97±22.03 pg/mL for those with inactive disease and this difference was statistically significant (P=0.0161). Similar results were obtained for IL-1β (P=0.0002). Correlation between IL-6, TNF-α, and IL-1β serum levels and SLEDAI score was observed (r=0.20, r=0.27, and r=0.38, resp.). This study supports the role of these proinflammatory cytokines as inflammatory mediators in active stage of disease.http://dx.doi.org/10.1155/2014/385297
spellingShingle Vinod Umare
Vandana Pradhan
Milind Nadkar
Anjali Rajadhyaksha
Manisha Patwardhan
Kanjaksha K. Ghosh
Anita H. Nadkarni
Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
Mediators of Inflammation
title Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
title_full Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
title_fullStr Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
title_full_unstemmed Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
title_short Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
title_sort effect of proinflammatory cytokines il 6 tnf α and il 1β on clinical manifestations in indian sle patients
url http://dx.doi.org/10.1155/2014/385297
work_keys_str_mv AT vinodumare effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients
AT vandanapradhan effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients
AT milindnadkar effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients
AT anjalirajadhyaksha effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients
AT manishapatwardhan effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients
AT kanjakshakghosh effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients
AT anitahnadkarni effectofproinflammatorycytokinesil6tnfaandil1bonclinicalmanifestationsinindianslepatients